Natgas producer BKV looks to raise up to $315 mln in US IPO-February 2024-www.financetom.com

Natgas producer BKV looks to raise up to $315 mln in US IPO

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Natgas producer BKV looks to raise up to $315 mln in US IPO

Sep 16, 2024 12:27 PM

Sept 16 (Reuters) - Natural gas producer BKV Corporation

said on Monday it aims to raise up to $315 million in its

initial public offering in the United States.

Previous page： Soho House Reaches Agreement to Be Taken Private Next page： Analysis-Wall Street sees new obesity pills as priced near Wegovy and Zepbound

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Soho House Reaches Agreement to Be Taken Private

Aug 18, 2025

06:17 AM EDT, 08/18/2025 (MT Newswires) -- Soho House ( SHCO ) said Monday it has signed agreements to be taken private by an investor group led by MCR Hotels and its chief executive, Tyler Morse, in a deal representing a total enterprise value of roughly $2.7 billion. Shareholders of Soho House ( SHCO ) will receive a payout of...

Analysis-Wall Street sees new obesity pills as priced near Wegovy and Zepbound

Aug 18, 2025

SEATTLE (Reuters) -U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with their weight-loss injections, analysts and investors say, in a departure from the usual practice of charging more for new medicines despite pressure to cut prices. Neither drugmaker has disclosed pricing plans for their new daily oral...

Soho House Appoints Neil Thomson as Chief Financial Officer

Aug 18, 2025

06:21 AM EDT, 08/18/2025 (MT Newswires) -- Soho House & Co ( SHCO ) said Monday it has appointed Neil Thomson as chief financial officer, effective immediately. Thomson succeeds Thomas Allen, who will remain with the company through Aug. 29 to support the transition. Before joining Soho House ( SHCO ), Thomson served as CFO of Tasty Restaurant. He previously...

Novo Nordisk's Wegovy Snags Conditional FDA Nod For Fatty Liver Disease

Aug 18, 2025

On Saturday, the U.S. Food and Drug Administration (FDA) approved an additional indication for Novo Nordisk A/S’ Wegovy (semaglutide 2.4 mg) based on a supplemental New Drug Application (sNDA) for noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), in combination with a reduced calorie diet and increased physical...